Delivery Order SPE2DB20D1109-SPE2DB22FP42G
- Not listed
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Lantus SoloStar 100 unit/mL 3mL insulin pens. The $1,937.68 firm fixed-price contract has an ultimate completion date of August 3, 2021. AmerisourceBergen, a subsidiary of the parent company Cencora, Inc., holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Lantus SoloStar 100 units/mL 3mL insulin pens. The award, valued at $1,424.64, was made by the Defense Logistics Agency (DLA) under a delivery order and has a firm fixed price. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The award, with a ceiling value of $7,696.63, is for the delivery of Lantus Solostar insulin pens. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Lantus Solostar 100 unit/ml 3ml insulin pens. The contract has a ceiling value of $4,128.50 and is a firm-fixed price delivery order, with a period of performance ending on May 31, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999. The delivery order is for 4,556,690 units of Lantus Solostar 100 unit/mL 3mL, a medication used to treat diabetes. The delivery order has a firm fixed price of $1,565.70 and a completion date of March 28, 2022. The contract was awarded on an unrestricted basis, with no set-aside...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract worth $1,943.76 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of Lantus SoloStar 100 Unit/mL 3mL insulin pens. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to AmerisourceBergen Drug Corp, with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Lantus Solostar 100 unit/mL 3mL insulin pens. The $1,151.88 firm fixed price Delivery Order was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) on June 21, 2024, with a completion date of June 24, 2024. The contract does not have a set-aside designation. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support...
- This is a $1,121.04 delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of Lantus Solostar insulin pens. The delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The...
- This federal contract award is for the delivery of Lantus Solostar 100 Unit/ML 3ML insulin pens to the Defense Logistics Agency (DLA). The $1,980.20 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on December 9, 2024. The contract has an ultimate completion date of December 10, 2024 and is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Lantus Solostar insulin pens to the U.S. government. The $1,119.16 firm fixed-price delivery order was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA). Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB22FP42GDelivery Order
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at $999,999,999. The delivery order, valued at $3,514.49, is for Lantus Solostar 100 unit/mL 3mL insulin pens. The contract has a firm fixed price pricing type and a period of performance through June 14, 2022. This delivery order is not designated as a set-aside contract. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also maintains an IDC with the Department of Justice Federal Bureau of Investigation valued at up to $750,000 for similar medical products and prescription drugs. These IDCs enable the government to efficiently procure essential pharmaceutical and medical supplies to support military, veterans, and other federal healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.5k | 6/13/22 |